Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NYPRG-101 by Ceruvia Lifesciences for Alcohol Dependence: Likelihood of Approval
NYPRG-101 is under clinical development by Ceruvia Lifesciences and currently in Phase I for Alcohol Dependence. According to GlobalData, Phase...
Data Insights
NYPRG-101 by Ceruvia Lifesciences for Opium (Opioid) Addiction: Likelihood of Approval
NYPRG-101 is under clinical development by Ceruvia Lifesciences and currently in Phase I for Opium (Opioid) Addiction. According to GlobalData,...